Page 297 - Total War on PTSD

Our Work: We further our mission by: developing psychedelics and marijuana into prescription medicines; training therapists and working to establish a network of treatment centers; supporting scientific research into spirituality, creativity, and neuroscience; and educating the public honestly about the risks and benefits of psychedelics and marijuana.
Our Vision: We envision a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.
Our Values:
Transparency — Information is shared openly and clearly. Communications are respectful, honest, and forthright.
Passion and Perseverance — We persist in the face of challenges. We have a sense of urgency about our work, and know that it's a long-term effort.
Intelligent Risk — Our decisions are informed by research. We try new things and learn from our mistakes.
Trust and Accountability — We value integrity and honesty, and embrace high standards.
Our highest priority project is funding clinical trials of 3,4 - methylenedioxymethamphetamine (MDMA) as a tool to assist psychotherapy for the treatment of Post-Traumatic Stress Disorder (PTSD). Preliminary studies have shown that MDMA in conjunction with psychotherapy can help people overcome PTSD, and possibly other disorders as well. MDMA is known for increasing feelings of trust and compassion towards others, which could make an ideal adjunct to psychotherapy for PTSD.
297 of 1042